Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure

Details

Files
Project Status:
Completed
Project Line:
Reference List
Project Sub Line:
Summary of Abstracts
Project Number:
RB1633-000
Effective finish date:

Question

  1. What literature describes the potential clinical benefits and harms of sodium-glucose cotransporter-2 inhibitors in adults with heart failure?

Key Message

We found 9 systematic reviews and 23 randomized controlled trials describing the potential clinical benefits and harms of sodium-glucose cotransporter-2 (SGLT2) inhibitors in adults with heart failure.